IPO registrations (S-1, F-1) · Registrants
Fibrocell Science, Inc.
- SEC CIK
- 357097 · filings on EDGAR ↗
- Former names
- ISOLAGEN INC (2002–2009); AMERICAN FINANCIAL HOLDING INC /DE (1996–2001)
- Registration
- Form S-1, first filed 2003-09-12, last 2018-07-27; 15 initial registrations, 22 amendments
- Outcome
- Final prospectus filed 2004-06-10; declared effective 2007-07-11; withdrawal requested 2007-08-15
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 405 EAGLEVIEW BOULEVARD, Exton, PA 19341
- EIN
- 87-0458888
- EDGAR entity type
- operating
- Insiders and CEO pay
- Fibrocell Science, Inc. on the corporate pages
On this site
- Business registration: Fibrocell Science, Inc. Fuzzy (name and state)
- Form D issuer: Fibrocell Science, Inc. EXACT (CIK (EXACT))
- SEC filer: Fibrocell Science, Inc. EXACT (CIK (EXACT))
- Person page: James E Flynn Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther))
- Person page: Julian P Kirk Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 75
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2003-09-12 | S-1 | S-1 (registration) | ISOLAGEN INC | 0000950129-03-004644 ↗ |
| 2003-10-24 | S-1/A | S-1/A (amendment) | ISOLAGEN INC | 0000950129-03-005140 ↗ |
| 2003-11-12 | S-1/A | S-1/A (amendment) | ISOLAGEN INC | 0000950129-03-005504 ↗ |
| 2003-11-18 | S-1/A | S-1/A (amendment) | ISOLAGEN INC | 0000950134-03-015573 ↗ |
| 2003-11-19 | S-1/A | S-1/A (amendment) | ISOLAGEN INC | 0000950129-03-005746 ↗ |
| 2004-06-10 | 424B4 | 424B4 (final prospectus) | ISOLAGEN INC | 0001047469-04-020004 ↗ |
| 2007-07-11 | EFFECT | EFFECT (declared effective) | ISOLAGEN INC | 9999999995-07-002765 ↗ |
| 2007-08-15 | RW | RW (withdrawal request) | ISOLAGEN INC | 0001104659-07-062723 ↗ |
| 2007-08-22 | RW | RW (withdrawal request) | ISOLAGEN INC | 0001104659-07-064156 ↗ |
| 2009-11-27 | S-1 | S-1 (registration) | Fibrocell Science, Inc. | 0000950123-09-066404 ↗ |
| 2010-01-29 | S-1/A | S-1/A (amendment) | Fibrocell Science, Inc. | 0000950123-10-006828 ↗ |
| 2010-02-10 | S-1/A | S-1/A (amendment) | Fibrocell Science, Inc. | 0000950123-10-010842 ↗ |
| 2010-02-12 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-10-000502 ↗ |
| 2010-04-07 | S-1 | S-1 (registration) | Fibrocell Science, Inc. | 0000950123-10-032894 ↗ |
| 2010-05-07 | RW | RW (withdrawal request) | Fibrocell Science, Inc. | 0000950123-10-046450 ↗ |
| 2010-05-07 | S-1/A | S-1/A (amendment) | Fibrocell Science, Inc. | 0000950123-10-046454 ↗ |
| 2010-05-07 | S-1 | S-1 (registration) | Fibrocell Science, Inc. | 0000950123-10-046509 ↗ |
| 2010-06-10 | S-1/A | S-1/A (amendment) | Fibrocell Science, Inc. | 0000950123-10-057272 ↗ |
| 2010-06-10 | S-1/A | S-1/A (amendment) | Fibrocell Science, Inc. | 0000950123-10-057275 ↗ |
| 2010-06-21 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-10-001885 ↗ |
| 2010-06-21 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-10-001890 ↗ |
| 2010-11-18 | S-1 | S-1 (registration) | Fibrocell Science, Inc. | 0000950123-10-107094 ↗ |
| 2010-12-03 | S-1 | S-1 (registration) | Fibrocell Science, Inc. | 0000950123-10-110865 ↗ |
| 2010-12-03 | S-1 | S-1 (registration) | Fibrocell Science, Inc. | 0000950123-10-110871 ↗ |
| 2011-01-18 | S-1/A | S-1/A (amendment) | Fibrocell Science, Inc. | 0000950123-11-003450 ↗ |
| 2011-02-09 | S-1/A | S-1/A (amendment) | Fibrocell Science, Inc. | 0000950123-11-011055 ↗ |
| 2011-02-09 | S-1/A | S-1/A (amendment) | Fibrocell Science, Inc. | 0000950123-11-011057 ↗ |
| 2011-02-09 | S-1/A | S-1/A (amendment) | Fibrocell Science, Inc. | 0000950123-11-011060 ↗ |
| 2011-02-11 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-11-000424 ↗ |
| 2011-02-11 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-11-000426 ↗ |
| 2011-02-11 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-11-000427 ↗ |
| 2011-05-27 | S-1 | S-1 (registration) | Fibrocell Science, Inc. | 0000950123-11-054930 ↗ |
| 2011-06-23 | S-1/A | S-1/A (amendment) | Fibrocell Science, Inc. | 0000950123-11-061226 ↗ |
| 2011-06-24 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-11-001957 ↗ |
| 2011-09-02 | S-1 | S-1 (registration) | Fibrocell Science, Inc. | 0000950123-11-082155 ↗ |
| 2011-09-12 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-11-002694 ↗ |
| 2012-01-24 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-12-000279 ↗ |
| 2012-01-24 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-12-000280 ↗ |
| 2012-01-24 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-12-000281 ↗ |
| 2012-09-07 | S-1 | S-1 (registration) | Fibrocell Science, Inc. | 0001193125-12-385131 ↗ |
| 2012-09-07 | S-1 | S-1 (registration) | Fibrocell Science, Inc. | 0001193125-12-385154 ↗ |
| 2012-09-07 | S-1 | S-1 (registration) | Fibrocell Science, Inc. | 0001193125-12-385157 ↗ |
| 2012-09-07 | S-1 | S-1 (registration) | Fibrocell Science, Inc. | 0001193125-12-385167 ↗ |
| 2012-10-29 | S-1/A | S-1/A (amendment) | Fibrocell Science, Inc. | 0001193125-12-438144 ↗ |
| 2012-10-29 | S-1/A | S-1/A (amendment) | Fibrocell Science, Inc. | 0001193125-12-438145 ↗ |
| 2012-10-29 | S-1/A | S-1/A (amendment) | Fibrocell Science, Inc. | 0001193125-12-438150 ↗ |
| 2012-10-29 | S-1/A | S-1/A (amendment) | Fibrocell Science, Inc. | 0001193125-12-438157 ↗ |
| 2012-11-20 | S-1/A | S-1/A (amendment) | Fibrocell Science, Inc. | 0001193125-12-476142 ↗ |
| 2012-11-20 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-12-003326 ↗ |
| 2012-11-20 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-12-003327 ↗ |
| 2012-11-20 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-12-003328 ↗ |
| 2012-11-20 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-12-003329 ↗ |
| 2013-01-22 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-13-000243 ↗ |
| 2013-01-22 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-13-000244 ↗ |
| 2013-07-15 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-13-002075 ↗ |
| 2013-08-23 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-13-002492 ↗ |
| 2013-08-23 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-13-002493 ↗ |
| 2013-08-23 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-13-002494 ↗ |
| 2013-08-28 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-13-002536 ↗ |
| 2016-02-09 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-16-003714 ↗ |
| 2017-11-06 | S-1 | S-1 (registration) | Fibrocell Science, Inc. | 0001047469-17-006810 ↗ |
| 2017-11-17 | S-1/A | S-1/A (amendment) | Fibrocell Science, Inc. | 0001047469-17-007138 ↗ |
| 2017-12-04 | S-1/A | S-1/A (amendment) | Fibrocell Science, Inc. | 0001047469-17-007434 ↗ |
| 2017-12-06 | S-1/A | S-1/A (amendment) | Fibrocell Science, Inc. | 0001047469-17-007473 ↗ |
| 2017-12-06 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-17-003153 ↗ |
| 2017-12-08 | 424B4 | 424B4 (final prospectus) | Fibrocell Science, Inc. | 0001047469-17-007572 ↗ |
| 2018-07-27 | S-1 | S-1 (registration) | Fibrocell Science, Inc. | 0001628280-18-009708 ↗ |
| 2018-08-08 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-18-002047 ↗ |
| 2019-02-12 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-19-000197 ↗ |
| 2019-12-17 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-19-002831 ↗ |
| 2019-12-17 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-19-002832 ↗ |
| 2019-12-17 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-19-002833 ↗ |
| 2019-12-17 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-19-002834 ↗ |
| 2019-12-17 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-19-002835 ↗ |
| 2019-12-17 | EFFECT | EFFECT (declared effective) | Fibrocell Science, Inc. | 9999999995-19-002836 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| DEMARTINO RALPH V | Director | 7 | 2006–2008 | ||
| MORRELL STEVEN | Director | 8 | 2006–2008 | ||
| TOH HENRY Y L | Director | 7 | 2006–2008 | ||
| WEBB MARSHALL G | Director | 7 | 2006–2008 | ||
| CIALLELLA SUSAN STRANAHAN | Director,Officer; Other | CEO,President; Interim CEO,Executive VP & Sec; Interim CEO, Exec, VP & Sec.; President; President, Exec. VP & Sec. | 6 | 2006–2007 | |
| Greenspan Todd James | Officer | Chief Financial Officer; Corporate Controller; VP Finance & Corp Controller | 10 | 2006–2008 | |
| SCHMIEG MARTIN E | Officer | CFO, Sr. VP | 1 | 2006 | |
| DALY DECLAN | Director,Officer; Officer | CEO; CEO & CFO; CEO & President; CFO & COO; CFO & Exec. VP - Europe; CFO & Exec. VP-Europe; COO & CFO | 13 | 2006–2011 | |
| TETI NICHOLAS | Director; Director,Officer; Officer | Cheif Executive Officer; Chief Executive Officer | 5 | 2006–2008 | |
| Trider Steven | Officer | Senior VP - Americas | 4 | 2006–2008 | |
| ROTH MICHAEL | TenPercentOwner | 20 | 2006–2009 | ||
| STARK BRIAN JAY | TenPercentOwner | 20 | 2006–2009 | ||
| VANDEWARKER TERRY E | Director | 6 | 2006–2008 | ||
| Calman Sandra | Officer | Chief Medical Officer & V.P. | 5 | 2007–2008 | |
| Selzer Kenneth A | Director | 5 | 2007–2008 | ||
| Hopper Paul | Director | 2 | 2009 | ||
| Moore Kelvin | Director | 13 | 2009–2019 | ||
| LANGER ROBERT | Director | 3 | 2009–2011 | ||
| Pernock David | Director; Director,Officer; Director,Officer,TenPercentOwner | Chairman and CEO; Chief Executive Officer | 17 | 2009–2016 | |
| AKANTHOS CAPITAL MANAGEMENT LLC | TenPercentOwner | 1 | 2009 | ||
| Michael Kao | TenPercentOwner | 1 | 2009 | ||
| DEERFIELD CAPITAL LP | TenPercentOwnerOther | 2 | 2010 | ||
| Deerfield Special Situations Fund, L.P. | TenPercentOwnerOther | 2 | 2010 | ||
| Flynn James E | TenPercentOwnerOther | 2 | 2010 | person page Fuzzy | |
| Mazur Marc | Director | 14 | 2010–2019 | ||
| Korkos George J | Director | 5 | 2010–2012 | ||
| DEERFIELD MANAGEMENT CO /NY | TenPercentOwnerOther | 1 | 2010 | ||
| Deerfield Special Situations Fund International LTD | TenPercentOwnerOther | 1 | 2010 | ||
| INTREXON CORP | TenPercentOwner | 10 | 2012–2019 | ||
| Kirk Julian P. | Director | 10 | 2012–2019 | person page Fuzzy | |
| KIRK RANDAL J | TenPercentOwner | 10 | 2012–2019 | ||
| NRM VII Holdings I, LLC | Director,TenPercentOwner | 1 | 2012 | ||
| Smith Marcus E. | Director | 10 | 2012–2019 | ||
| St.Clare Christine | Director | 11 | 2013–2019 | ||
| Swirsky Douglas J | Director | 10 | 2013–2019 | ||
| WEAVER GREGORY L | Officer | Chief Financial Officer | 4 | 2013–2014 | |
| Sheroff Robert James | Officer | See Remarks; VP, Technical Operations | 3 | 2014–2015 | |
| Maslowski John Michael | Director,Officer; Officer | CEO; SVP, Scientific Affairs; V.P., Scientific Affairs; VP, Scientific Affairs | 10 | 2014–2019 | |
| Smith Kimberly M. | Officer | Interim CFO/Treas/Secy; Principal Accounting Officer | 3 | 2014–2016 | |
| Goldan Keith A. | Officer | SVP and CFO | 3 | 2015–2016 | |
| Marino Michael F III | Officer | SVP and General Counsel | 3 | 2015–2016 | |
| Buckley Sean D. | Officer | Chief Financial Officer; See Remarks | 4 | 2018–2019 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2018-12-20 | Fibrocell Science, Inc. | Biotechnology | $900,000 | $900,000 | 2 | 1 |
| 2018-07-17 | Fibrocell Science, Inc. | Biotechnology | $3,064,216 | $3,064,216 | 3 | 1 |
| 2018-06-13 | Fibrocell Science, Inc. | Biotechnology | $5,087,980 | $5,087,980 | 4 | 1 |
| 2016-08-24 | Fibrocell Science, Inc. | Biotechnology | $25,000,000 | $17,625,000 | 14 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.